AG 17
Latest Information Update: 07 Feb 2001
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Tyrphostins
- Mechanism of Action Apoptosis stimulants; Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Feb 2001 No-Development-Reported for Cancer in Israel (Unknown route)
- 10 Nov 1998 New profile
- 10 Nov 1998 Preclinical development for Cancer in Israel (Unknown route)